Print（PDF/186KB） May 14, 2024 Corporate

Sumitomo Pharma Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura; Securities Code: 4506, Prime Market of TSE) announced today that in its meeting held on May 14, 2024, the Board of Directors appointed the following candidates for new assignments of Representative Directors including President and CEO, new members of the Board of Directors, and a new Executive Officer. The Company will also change the positions assumed by Executive officers.

I. Changes in Representative Directors (including President and CEO) and Executive Officer

(1) New Assignments of Representative Directors (including President and CEO) and Executive Officer

Name	New position	Current position
Toru Kimura	Representative Director, President and CEO	Representative Director, Senior Managing Executive Officer
Motoyuki Sakai	Representative Director, Executive Vice President	Representative Director & Senior Managing Executive Officer Sumitomo Chemical Co., Ltd.
Hiroshi Nomura	Corporate Senior Executive Advisor	Representative Director, President and CEO

(2) Reason for Changes

The Company has been facing challenging performance with significant losses in both the fiscal year ended March 31, 2023 and the fiscal year ended March 31, 2024, which are net profit attributable to owners of the parent. To achieve an early recovery in performance and regrowth, the Company is implementing various measures and receiving personnel support from Sumitomo Chemical Co., Ltd. Consequently, the Company has decided to transition to a new management structure led by a new President and CEO and a new Executive Vice President, with the full cooperation of the entire company, aiming to turn its performance into profitability.

(3) Effective Date

June 25, 2024 (The new members who will take office as of June 25, 2024 are subject to the approval at the general shareholders' meeting scheduled for the same date and then to be formally decided at the Board of Directors scheduled for the same date.)

II. Changes in the Members of the Board of Directors (effective June 25, 2024)

(1) New Members of the Board of Directors

Name	New position	Current position
Tsutomu Nakagawa	Member, Board of Directors, Executive Officer	Executive Officer
Hiroshi Niinuma	Member, Board of Directors	Director & Executive Vice President Sumitomo Chemical Co., Ltd.

The new members of the Board of Directors who will take office as of June 25, 2024 are subject to the approval at the general shareholders' meeting scheduled for the same date.
Hiroshi Niinuma is a candidate for non-executive Director and continues to serve as a Director & Executive Vice President of Sumitomo Chemical Co., Ltd. (concurrent position).

(2) Departing Members of the Board of Directors

Name	New position	Current position
Yoshiharu Ikeda	Managing Executive Officer	Member, Board of Directors, Managing Executive Officer
Hiroyuki Baba	Managing Executive Officer	Member, Board of Directors, Managing Executive Officer
Shigeyuki Nishinaka	Managing Executive Officer	Member, Board of Directors, Managing Executive Officer

III. Changes in the Positions Assumed by Executive Officers (effective June 25, 2024)

Position as of June 25, 2024	Current position	Name
Representative Director, Executive Vice President Global Corporate Strategy Corporate Governance Human Resources Global Finance Administration	Representative Director & Senior Managing Executive Officer Sumitomo Chemical Co., Ltd.	Motoyuki Sakai
Executive Officer Global Corporate Strategy Global Finance Vice President, Head of Global Corporate Strategy	Executive Officer Vice President, Head of Global Corporate Strategy	Yutaka Wakemi

(Reference) Brief Personal History of New President and CEO

Business Career
April 1989	Joined Sumitomo Chemical Co., Ltd.
October 1992	Joined the former Sumitomo Pharmaceuticals Co., Ltd.
June 2009	Vice President, Head of Genomic Science Laboratories of the Company
June 2010	Vice President, Head of Research Planning & Management of the Company
April 2012	Vice President, Head of Global Strategy of the Company
September 2013	Vice President, Head of the Regenerative & Cellular Medicine Office of the Company
April 2015	Executive Officer of the Company Vice President, Head of the Regenerative & Cellular Medicine Office
June 2016	Member of the Board of Directors and Executive Officer of the Company Vice President, Head of Global Corporate Strategy Regenerative & Cellular Medicine Office
October 2017	Member of the Board of Directors and Executive Officer of the Company Senior Executive Research Director of Drug Research Division Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center
April 2019	Member of the Board of Directors and Managing Executive Officer of the Company Senior Executive Research Director of Drug Research Division Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant
April 2020	Member of the Board of Directors and Managing Executive Officer of the Company Chief Scientific Officer Senior Executive Research Director of Drug Research Division Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant
April 2021	Representative Director and Senior Managing Executive Officer of the Company Chief Scientific Officer Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant
April 2022	Representative Director and Senior Managing Executive Officer of the Company Global Corporate Strategy; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant
April 2023	Representative Director and Senior Managing Executive Officer of the Company Global Corporate Strategy; Global Finance; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant (to the present)

(Reference) Brief Personal History of candidates for new members of the Board of Directors

1. Motoyuki Sakai　　　　　Birthdate: August 14, 1961

April 1985	Joined Sumitomo Chemical Co., Ltd.
June 2007	General Manager, Finance & Accounting Office (Accounting), Sumitomo Chemical Co., Ltd.
July 2010	General Manager, Corporate Planning & Coordination Office (Corporate Planning), Sumitomo Chemical Co., Ltd.
April 2013	General Manager, Corporate Planning & Coordination Office (Business Development), Sumitomo Chemical Co., Ltd.
April 2014	Executive Officer, Sumitomo Chemical Co., Ltd.
April 2018	Managing Executive Officer, Sumitomo Chemical Co., Ltd. President and Representative Director, Sumitomo Chemical Asia Pte Ltd
April 2023	Senior Managing Executive Officer, Sumitomo Chemical Co., Ltd.
June 2023	Representative Director & Senior Managing Executive Officer, Sumitomo Chemical Co., Ltd. (to the present)

Company shares owned: 0

2. Tsutomu Nakagawa　　　　　　Birthdate: April 27, 1968

April 1993	Joined the former Sumitomo Pharmaceuticals Co., Ltd.
April 2016	Senior Officer of Global Oncology of the Company
April 2017	Senior Officer of Global Oncology (Development Strategy) of the Company
April 2019	Vice President, Head of Global Oncology Office of the Company
April 2020	Vice President, Head of Global Corporate Strategy of the Company
April 2022	Executive Officer of the Company
July 2023	Chief Strategy Officer of Sumitomo Pharma America, Inc.
April 2024	President and CEO of Sumitomo Pharma America, Inc. (to the present)

3. Hiroshi Niinuma　　　　　　　Birthdate: March 5, 1958

April 1981	Joined Sumitomo Chemical Co., Ltd.
April 2006	General Manager, Personnel Office, Sumitomo Chemical Co., Ltd.
April 2007	General Manager, Human Resources Dept., Sumitomo Chemical Co., Ltd.
April 2009	General Manager, General Affairs Dept., Sumitomo Chemical Co., Ltd.
April 2010	Executive Officer, Sumitomo Chemical Co., Ltd.
April 2013	Managing Executive Officer, Sumitomo Chemical Co., Ltd.
April 2018	Senior Managing Executive Officer, Sumitomo Chemical Co., Ltd.
June 2018	Director & Senior Managing Executive Officer, Sumitomo Chemical Co., Ltd.
April 2022	Director & Executive Vice President, Sumitomo Chemical Co., Ltd. (to the present)

(Reference) Members of the Board of Directors and the Audit & Supervisory Board after approval at the general shareholders' meeting (from June 25, 2024)

　Board of Directors

Toru Kimura	Representative Director, President and CEO
Motoyuki Sakai	Representative Director, Executive Vice President
Tsutomu Nakagawa	Member, Board of Directors, Executive Officer
Hiroshi Niinuma	Member, Board of Directors
Saeko Arai	Member, Board of Directors (Outside)
Nobuhiro Endo	Member, Board of Directors (Outside)
Minoru Usui	Member, Board of Directors (Outside)
Koji Fujimoto	Member, Board of Directors (Outside)

　Audit & Supervisory Board

Takashi Kutsunai	Audit & Supervisory Board Member
Hisayoshi Kashima	Audit & Supervisory Board Member
Yoshio Iteya	Audit & Supervisory Board Member (Outside)
Mayumi Mochizuki	Audit & Supervisory Board Member (Outside)
Daishiro Michimori	Audit & Supervisory Board Member (Outside)